Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool

Fertility and Sterility

Volumn 103, Issue 4, 2015, Pages 1074-1080.e4

  Anderson, Richard A ^a   Anckaert, Ellen ^b   Bosch, Ernesto ^c   Dewailly, Didier ^d   Dunlop, Cheryl E ^a   Fehr, Daniel ^e   Nardo, Luciano ^f   Smitz, Johan ^b   Tremellen, Kelton ^g   Denk, Barbara ^h   Geistanger, Andrea ^h   Hund, Martin ⁱ  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c IVI Valencia   (Spain)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^f GyneHealth   (United Kingdom)

^g Repromed   (Australia)

^h ROCHE DIAGNOSTICS GMBH   (Germany)

ⁱ Roche Diagnostics Ltd   (Switzerland)

Author keywords

Antim llerian hormone; Antral follicle count; Ovarian follicle; Ovarian reserve; Reproductive life span

Indexed keywords

BIOLOGICAL MARKER; ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; AUTOMATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY ANALYZER; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MULTICENTER STUDY; OBSERVATIONAL STUDY; OVARIAN RESERVE; OVARY FOLLICLE DEVELOPMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; STATISTICAL SIGNIFICANCE; ADOLESCENT; BLOOD; BLOOD ANALYSIS; CELL COUNT; CYTOLOGY; DEVICES; EVALUATION STUDY; INFERTILITY, FEMALE; LABORATORY AUTOMATION; OVARY FOLLICLE; OVULATION INDUCTION; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-MULLERIAN HORMONE; AUTOMATION, LABORATORY; BLOOD CHEMICAL ANALYSIS; CELL COUNT; FEMALE; HUMANS; INFERTILITY, FEMALE; OVARIAN FOLLICLE; OVARIAN RESERVE; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; YOUNG ADULT;

EID: 84929487183     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2015.01.004     Document Type: Article

References (25)

1. Broekmans FJ, Kwee J, Hendriks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006;12:685-718.
2. Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, et al. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-mullerian hormone and response to controlled ovarian stimulation. Fertil Steril 2010;94:1775-81.
3. Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: A meta-analysis. Hum Reprod Update 2011;17:46-54.
4. La Marca A, Sunkara SK. Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update 2014;20:124-40.
5. Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, et al. Definition and significance of polycystic ovarian morphology: A task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2014;20:334-52.
6. Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, et al. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: An individual patient data approach. Hum Reprod Update 2013;19:26-36.
7. Broekmans FJ, de Ziegler D, Howles CM, Gougeon A, Trew G, Olivennes F. The antral follicle count: practical recommendations for better standardization. Fertil Steril 2010;94:1044-51.
8. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, et al. Anti-mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83.
9. Jeppesen JV, Anderson RA, Kelsey TW, Christiansen SL, Kristensen SG, Jayaprakasan K, et al. Which follicles make the most anti-mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod 2013;19:519-27.
10. Iliodromiti S, Kelsey TW, Wu O, Anderson RA, Nelson SM. The predictive accuracy of anti-mullerian hormone for live birth after assisted conception: A systematic review and meta-analysis of the literature. Hum Reprod Update 2014;20:560-70.
11. Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-mullerian hormone in women. Hum Reprod Update 2014;20:370-85.
12. Rustamov O, Smith A, Roberts SA, Yates AP, Fitzgerald C, Krishnan M, et al. Anti-mullerian hormone: poor assay reproducibility in a large cohort of subjects suggests sample instability. Hum Reprod 2012;27:3085-91.
13. Gassner D, Jung R. First fully automated immunoassay for anti-mullerian hormone. Clin Chem Lab Med 2014;52:1143-52.
14. Bonett DG, Wright TA. Sample size requirements for estimating Pearson, Kendall and Spearman correlations. Psychometrika 2000;65:23-8.
15. van Tilborg TC, Eijkemans MJ, Laven JS, Koks CA, de Bruin JP, Scheffer GJ, et al. The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial. BMC Womens Health 2012;12:29.
16. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: The Bologna criteria. Hum Reprod 2011;26: 1616-24.
17. Deb S, Jayaprakasan K, Campbell BK, Clewes JS, Johnson IR, Raine-Fenning NJ. Intraobserver and interobserver reliability of automated antral follicle counts made using three-dimensional ultrasound and SonoAVC. Ultrasound Obstet Gynecol 2009;33:477-83.
18. Elter K, Sismanoglu A, Durmusoglu F. Intercycle variabilities of basal antral follicle count and ovarian volume in subfertile women and their relationship to reproductive aging: A prospective study.Gynecol Endocrinol 2005;20:137-43.
19. La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, et al. Antim ullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 2004;19:2738-41.
20. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te Velde ER, Broekmans FJ. Anti-mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006;91: 4057-63.
21. van Disseldorp J, Lambalk CB, Kwee J, Looman CW, Eijkemans MJ, Fauser BC, et al. Comparison of inter-and intra-cycle variability of antim ullerian hormone and antral follicle counts. Hum Reprod 2010;25:221-7.
22. Schiettecatte J, Oktem M, Theis A, Cohen-Bacrie M, Anckaert E, Muller C, et al. Elecsys AMH immunoassay: A multicenter evaluation of the precision of a novel fully automated AMH assay under routine conditions. Presented at the IFCC WorldLab Congress, Istanbul, Turkey, 2014.
23. Andersen AN, Witjes H, Gordon K, Mannaerts B, Xpect investigators. Predictive factors of ovarian response and clinical outcome after IVF/ICSI following a rFSH/GnRH antagonist protocol with or without oral contraceptive pretreatment. Hum Reprod 2011;26:3413-23.
24. Arce JC, La Marca A, Mirner Klein B, Nyboe Andersen A, Fleming R. Antim ullerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril 2013;99:1644-53.
25. Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-mullerian hormone (AMH) and antral follicle count (AFC) as biomarkers of ovarian response. Hum Reprod Update 2014 Dec 8. pii: dmu062. [Epub ahead of print].